The Latest Breaking News from MedTech

Ashley McEvoy pivoted from over-the-counter products to medical devices.

Fortune has identified 11 CEO stars in the making—many of them already in the C-suite, and all potential large-company CEOs.

PCR testing in December 2021 and January 2022 was "armageddon".

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck &…

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy is likely to enter a recession, making pharma stocks attractive investment options. Therefore, investors could look to…

The recent financial turmoil from several bank failures, the Fed’s persistent hawkish stance to battle stubborn inflation, and renewed recession worries have kept the stock market highly volatile lately. Amid this backdrop, investors could consider buying fundamentally sound, large-cap stocks Taiwan Semiconductor (TSM), Johnson & Johnson (JNJ), and Merck (MRK),…

The recent bank failures have increased the likelihood of a recession, with many economists increasing the odds of an economic slump in the next 12 months. Amid this backdrop, investors could buy fundamentally strong stocks, Johnson & Johnson (JNJ) and Pfizer (PFE), which could help retire a millionaire. Read on.

The Silicon Valley Bank crisis will likely deter the Fed from raising interest rates by the expected 50 basis points next week. However, since the market is expected to remain highly volatile, it could be wise to invest in fundamentally strong stocks Johnson & Johnson (JNJ), Walmart (WMT), and General…

As the Fed is expected to raise interest rates higher than expected, the revived recession fears will keep the stock market under pressure in the upcoming months. Thus, it could be wise to scoop up shares of high-quality businesses, such as Johnson & Johnson (JNJ), Humana Inc. (HUM), and AutoZone,…

Due to a barrage of strong macroeconomic data, the Federal Reserve has expressed the need to keep interest rates elevated. This is expected to keep the market volatile. Amid this backdrop, it might be wise to buy fundamentally strong dividend stocks Johnson & Johnson (JNJ), Novartis (NVS), and ARC Document…

With higher-than-expected job gain and inflation, concerns about the Fed’s tight monetary policy pushing the economy into a recession still loom large. Therefore, investors could look to buy fundamentally strong and profitable stocks, Johnson & Johnson (JNJ), Canon (CAJ), and Forrester Research (FORR). Keep reading….